Cover Image

The Role of Metabolic Dysfunction-Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study

BackgroundThe association between metabolic dysfunction-associated fatty liver disease (MAFLD) and chronic kidney disease (CKD) is unclear. ObjectiveThis longitudinal cohort study aimed to test whether MAFLD plays an important role in the development of CKD. MethodsThis cohort study included 41,246...

Full description

Saved in:

Bibliographic Details
Main Authors:	Suosu Wei (Author), Jian Song (Author), Yujie Xie (Author), Junzhang Huang (Author), Jianrong Yang (Author)
Format:	Book
Published:	JMIR Publications, 2023-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of metabolic dysfunction-associated fatty liver disease, type 2 diabetes mellitus, and metabolic goal achievement with risk of chronic kidney disease
by: Weitao Su, et al.
Published: (2022)

Metabolic dysfunction-associated fatty liver disease/metabolic dysfunction-associated steatotic liver disease: general provisions
by: O.E. Abaturov, et al.
Published: (2024)

Genetic predisposition to metabolic dysfunction-associated fatty liver disease
by: O.E. Abaturov, et al.
Published: (2024)

Chronic Kidney Disease and Nonalcoholic Fatty Liver Disease Proven by Transient Elastography
by: Ivana Mikolasevic, et al.
Published: (2013)

Pathological Connections between Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease
by: Huixia Liu, et al.
Published: (2022)

Dietary patterns and metabolic dysfunction-associated fatty liver disease in China's multi-ethnic regions
by: Xingren Zhu, et al.
Published: (2023)

Associations of an overall healthy lifestyle with the risk of metabolic dysfunction-associated fatty liver disease
by: Caimei Yuan, et al.
Published: (2024)

Aberrant DNA methylation associated with the development of metabolic dysfunction-associated fatty liver disease
by: O.E. Abaturov, et al.
Published: (2024)

Impact of anthropometric parameters on outcomes in Asians with metabolic dysfunction‐associated fatty liver disease
by: Kyu Yeon Choi, et al.
Published: (2023)

Fatty liver associated with metabolic derangement in patients with chronic kidney disease: A controlled attenuation parameter study
by: Chang-Yun Yoon, et al.
Published: (2017)

Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease
by: Xiaoyan Cai, et al.
Published: (2021)

Associations of metal mixtures with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2003-2018
by: Zhilan Xie, et al.
Published: (2023)

Metabolic-associated fatty liver disease and lipoprotein metabolism
by: Joerg Heeren, et al.
Published: (2021)

The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review
by: Kiana Mohammadian, et al.
Published: (2024)

Comparing diabetes prediction based on metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease: the ELSA-Brasil study
by: Gabriela Wünsch Lopes, et al.
Published: (2024)

Metabolic-Associated Fatty Liver Disease: The Influence of Oxidative Stress, Inflammation, Mitochondrial Dysfunctions, and the Role of Polyphenols
by: Raissa Bulaty Tauil, et al.
Published: (2024)

Risk stratification using sarcopenia status among subjects with metabolic dysfunction‐associated fatty liver disease
by: Ho Soo Chun, et al.
Published: (2021)

Liver Cell Mitophagy in Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
by: Jiaxin Chen, et al.
Published: (2024)

Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context
by: Laure Monteillet, et al.
Published: (2018)

Metabolic drivers of non-alcoholic fatty liver disease
by: Kendra K. Bence, et al.
Published: (2021)

METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD) AND CARDIOMETABOLIC HEALTH EDUCATIONAL INITIATIVE WITH INTERNAL MEDICINE RESIDENTS
by: Jack Jnani, MD
Published: (2024)

Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Thyroid Function in Childhood Obesity: A Vicious Circle?
by: Valeria Calcaterra, et al.
Published: (2024)

The relationship between metabolic dysfunction‐associated fatty liver disease and low muscle mass in an asymptomatic Korean population
by: Ji Yeon Seo, et al.
Published: (2022)

Complement C3 and Nonalcoholic Fatty Liver Disease in Chronic Kidney Disease Patients: A Pilot Study
by: Binbin Pan, et al.
Published: (2020)

Chronic liver diseases and erectile dysfunction
by: Guanghui Zang, et al.
Published: (2023)

Thyroid dysfunction in obese adults in relation to nonalcoholic fatty liver disease
by: Fatema Abu Bakr Abdel-Moez, et al.
Published: (2019)

Thyroid dysfunction and insulin resistance in patients with nonalcoholic fatty liver disease
by: Maha Assem, et al.
Published: (2018)

Immune dysfunction in chronic kidney disease
by: Sara Cardoso Fernandes, et al.
Published: (2021)

Targeting ketone body metabolism to treat fatty liver disease
by: Sora Kwon, et al.
Published: (2024)

Hepatoprotective Effect of Bee Bread in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Rats: Impact on Oxidative Stress and Inflammation
by: Zaida Zakaria, et al.
Published: (2021)

Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway
by: Jinbiao He, et al.
Published: (2022)

Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis
by: Sandip Mukherjee, et al.
Published: (2021)

Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver disease
by: Marica Meroni, et al.
Published: (2020)

Advance in Iron Metabolism, Oxidative Stress and Cellular Dysfunction in Experimental and Human Kidney Diseases
by: Tiancheng Xie, et al.
Published: (2024)

The Role of Lipid and Lipoprotein Metabolism in Non‐Alcoholic Fatty Liver Disease
by: Francesco Massimo Perla, et al.
Published: (2017)

Chronic Metabolic Acidosis in Chronic Kidney Disease
by: Daniel Patschan, et al.
Published: (2020)

Severe liver dysfunction in an infant with cystic fibrosis masquerading as metabolic liver disease
by: K P Srikanth, et al.
Published: (2016)

Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Emidio Scarpellini, et al.
Published: (2024)

The Role of L-Carnitine in Kidney Disease and Related Metabolic Dysfunctions
by: Tim Ulinski, et al.
Published: (2023)

Associations of serum folate and vitamin C levels with metabolic dysfunction-associated fatty liver disease in US adults: A nationwide cross-sectional study
by: Yuqi Jiang, et al.
Published: (2022)